Teva halts production at sterile injectables plant to address FDA concerns | Fierce Pharma
Teva's troubled Godollo plant earns firm US FDA warning letter
FDA Warning Letter Reveals Data and Sterility Issues at Teva Plant in Hungary | RAPS
Teva plant tagged with warning letter for issues making schizophrenia drug | Fierce Pharma
500 jobs to go as Teva exits troubled Hungary plant
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva Pharma Receive Warning Letter - Parker Waichman LLP
Teva's troubled Godollo plant earns firm US FDA warning letter
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva's troubled Godollo plant earns firm US FDA warning letter
The most damning FDA rebukes of the COVID era
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
The most damning FDA rebukes of the COVID era
Teva's troubled Godollo plant earns firm US FDA warning letter
Teva wants to join Big PhRMA with an ongoing FDA Import Alert for Deficient cGMP
U.S. charges Teva in generic drugs price-fixing probe
Teva laying off 500 at struggling sterile injectables plant in Hungary | Fierce Pharma
FDA cites 'significant' sterility concern at Teva injectables plant | Fierce Pharma
500 jobs to go as Teva exits troubled Hungary plant
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Troubled Teva plant in Hungary faces an FDA crackdown - STAT
Teva confirms it halted production at Hungary injectables plant in January
Teva receives warning letter over Actavis site
Teva's struggling sterile plant hit with FDA warning letter - Skyland Analytics
